Funded Tech Companies
EyeBio
Wondering who provided funding to EyeBio? Jeito Capital, Omega Funds and Bain Capital Life Sciences put venture money into this biopharmaceutical company.
Company Overview
Company Name
EyeBio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
International Building 71 Kingsway
London, England, WC2B 6ST
UK
London, England, WC2B 6ST
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
EyeBio is a clinical-stage ophthalmology biotech company that brings together an experienced team of leaders, innovators, and entrepreneurs to develop a new generation of therapies for eye diseases. We understand what it takes to establish a new standard of care in ophthalmology. Our co-founders, Dr. David Guyer and Dr. Anthony P. Adamis, created and led the company that introduced the first anti-vascular endothelial growth factor (anti-VEGF) therapy for patients with age-related macular degeneration (AMD).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/14/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Guyer
Chief Technical Officer
Joost Ouwerkerk
Co-Founder
Fred Lalonde
Co-Founder
Laurence Tosi
Company Investors
- Jeito Capital
- Omega Funds
- Bain Capital Life Sciences
- MRL Ventures
- SV Health Investors
- Samsara BioCapital
- Vertex Ventures HC
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs